S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Something is Coming for America's Top Stock (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
Something is Coming for America's Top Stock (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
Something is Coming for America's Top Stock (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Something is Coming for America's Top Stock (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
Something is Coming for America's Top Stock (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
Something is Coming for America's Top Stock (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Something is Coming for America's Top Stock (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
Something is Coming for America's Top Stock (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
Something is Coming for America's Top Stock (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Something is Coming for America's Top Stock (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
Something is Coming for America's Top Stock (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
Something is Coming for America's Top Stock (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
NASDAQ:MDVL

MedAvail (MDVL) Stock Forecast, Price & News

$6.00
0.00 (0.00%)
(As of 10/2/2023 ET)
Compare
Today's Range
$6.00
▼
$6.00
50-Day Range
$0.28
▼
$11.99
52-Week Range
$5.19
▼
$47.50
Volume
38 shs
Average Volume
2,138 shs
Market Capitalization
$9.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

MedAvail MarketRank™ Forecast

Analyst Rating
0.00 Rating Score
Upside/​Downside
83.3% Downside
$1.00 Price Target
Short Interest
Healthy
0.50% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.43mentions of MedAvail in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$1,727 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.78 out of 5 stars

See Top Rated MarketRank™ Stocks Here

MDVL stock logo

About MedAvail (NASDAQ:MDVL) Stock

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona.

MDVL Price History

MDVL Stock News Headlines

August 30, 2023 | finance.yahoo.com
MedAvail to Participate in H.C. Wainwright 25th Annual Global Investment Conference
August 16, 2023 | finance.yahoo.com
Potential Upside For MedAvail Holdings, Inc. (NASDAQ:MDVL) Not Without Risk
October 3, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
August 15, 2023 | finanznachrichten.de
MedAvail Holdings, Inc.: MedAvail Reports Second Quarter 2023 Financial Results
August 14, 2023 | finance.yahoo.com
MedAvail Reports Second Quarter 2023 Financial Results
August 4, 2023 | finance.yahoo.com
MedAvail Announces Agreement with Dallas-Based Oak Lawn Pharmacy for Deployment of Ten M4 MedCenters
August 1, 2023 | finanznachrichten.de
MedAvail Holdings, Inc.: MedAvail Announces 1-for-50 Reverse Stock Split
July 31, 2023 | finanznachrichten.de
MedAvail Holdings, Inc.: MedAvail Announces Enhanced API Integration with its Largest Partner, Texas Health Resources
October 3, 2023 | Behind the Markets (Ad)
New Breakthrough "Living Software" Has Been…
New Breakthrough "Living Software" Has Been... Ukraine's "Secret Weapon" Against Russia The Washington Post Reports: "It's a big reason David is beating Goliath..." The Wall Street Journal Reports: "it's a technical revolution." Jeff Bezos Said: "It's in the realm of science fiction." Early investors can reap 5,633% gains on the small company revolutionizing warfare >>>
July 31, 2023 | finance.yahoo.com
MedAvail Announces 1-for-50 Reverse Stock Split
July 13, 2023 | finance.yahoo.com
MedAvail Announces Enhanced API Integration with its Largest Partner, Texas Health Resources
June 21, 2023 | benzinga.com
MedAvail Holdings Board Member Awarded $160K Worth of Stock Options
June 21, 2023 | benzinga.com
MedAvail Holdings Director Awarded $160K Worth of Stock Options
May 19, 2023 | finanznachrichten.de
MedAvail Holdings, Inc.: MedAvail Reports First Quarter 2023 Financial Results
May 18, 2023 | msn.com
MedAvail Holdings GAAP EPS of -$0.16, revenue of $0.62M
May 18, 2023 | msn.com
MedAvail Holdings: Q1 Earnings Insights
May 18, 2023 | finance.yahoo.com
MedAvail Reports First Quarter 2023 Financial Results
May 18, 2023 | finance.yahoo.com
MedAvail to Report First Quarter 2023 Financial Results on May 18
May 15, 2023 | finance.yahoo.com
MedAvail to Report First Quarter 2023 Financial Results on May 15
May 15, 2023 | finance.yahoo.com
MedAvail Postpones Reporting of First Quarter 2023 Financial Results
May 10, 2023 | marketwatch.com
8-K: MedAvail Holdings, Inc.
April 15, 2023 | finanznachrichten.de
MedAvail Holdings, Inc.: MedAvail Reports Fourth Quarter and Full-Year 2022 Financial Results
April 13, 2023 | finance.yahoo.com
MedAvail Reports Fourth Quarter and Full-Year 2022 Financial Results
April 12, 2023 | finance.yahoo.com
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13
March 30, 2023 | finance.yahoo.com
MedAvail Postpones Reporting of Fourth Quarter and FY 2022 Financial Results
March 29, 2023 | benzinga.com
MedAvail Holdings's Earnings: A Preview
March 29, 2023 | markets.businessinsider.com
What Wall Street expects from MedAvail's earnings
See More Headlines
Receive MDVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedAvail and its competitors with MarketBeat's FREE daily newsletter.

MDVL Company Calendar

Last Earnings
8/14/2023
Today
10/03/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Drug stores & proprietary stores
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MDVL
CUSIP
N/A
CIK
1402479
Web
www.medavail.com
Phone
(905) 812-0023
Fax
973-348-5707
Employees
279
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$1.00
High Stock Price Forecast
$1.00
Low Stock Price Forecast
$1.00
Forecasted Upside/Downside
-83.3%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($28.72)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-47,620,000.00
Net Margins
-192.97%
Pretax Margin
-157.41%
Return on Equity
-218.10%
Return on Assets
-103.45%

Debt

Debt-to-Equity Ratio
0.34
Current Ratio
6.34
Quick Ratio
4.64

Sales & Book Value

Annual Sales
$43.11 million
Price / Sales
0.22
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$13.01 per share
Price / Book
0.46

Miscellaneous

Outstanding Shares
1,610,000
Free Float
1,590,000
Market Cap
$9.66 million
Optionable
Not Optionable
Beta
0.54
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Mark Doerr RPh (Age 53)
    CEO, Pres & Director
    Comp: $424.42k
  • Ms. Ramona Seabaugh (Age 54)
    CFO, Treasurer & Sec.
    Comp: $367.94k
  • Ms. Joan O'Rourke
    Pres of SpotRx
  • Mr. Brian Schlerf
    Corp. Controller

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













MDVL Stock - Frequently Asked Questions

What is MedAvail's stock price forecast for 2023?

0 Wall Street research analysts have issued twelve-month target prices for MedAvail's stock. Their MDVL share price forecasts range from $1.00 to $1.00. On average, they predict the company's share price to reach $1.00 in the next twelve months. This suggests that the stock has a possible downside of 83.3%.
View analysts price targets for MDVL or view top-rated stocks among Wall Street analysts.

How have MDVL shares performed in 2023?

MedAvail's stock was trading at $0.2998 at the start of the year. Since then, MDVL stock has increased by 1,901.3% and is now trading at $6.00.
View the best growth stocks for 2023 here.

When is MedAvail's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our MDVL earnings forecast.

How were MedAvail's earnings last quarter?

MedAvail Holdings, Inc. (NASDAQ:MDVL) issued its earnings results on Monday, August, 14th. The company reported ($3.06) EPS for the quarter. The business had revenue of $0.41 million for the quarter. MedAvail had a negative trailing twelve-month return on equity of 218.10% and a negative net margin of 192.97%.

What is MedAvail's stock symbol?

MedAvail trades on the NASDAQ under the ticker symbol "MDVL."

How do I buy shares of MedAvail?

Shares of MDVL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MedAvail's stock price today?

One share of MDVL stock can currently be purchased for approximately $6.00.

How much money does MedAvail make?

MedAvail (NASDAQ:MDVL) has a market capitalization of $9.66 million and generates $43.11 million in revenue each year. The company earns $-47,620,000.00 in net income (profit) each year or ($28.72) on an earnings per share basis.

How many employees does MedAvail have?

The company employs 279 workers across the globe.

How can I contact MedAvail?

MedAvail's mailing address is 45 HORSEHILL ROAD SUITE 106, CEDAR KNOLLS NJ, 07927. The official website for the company is www.medavail.com. The company can be reached via phone at (905) 812-0023, via email at jgoodford@myoscorp.com, or via fax at 973-348-5707.

This page (NASDAQ:MDVL) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -